1 completed, 1 suspended, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Suspended 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Pathological Complete Response: new trials by email Literature Review of Pathological Complete Response trials Research Report on Pathological Complete Response
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer Fasting Mimicking diet program - Fasting Mimicking Diet, HER2-negative Breast Cancer | Phase 3 | Suspended | Leiden University Medical Center | 10 | 2023-03-17 | 2023-11-22 |
| Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy Epirubicin, Fluorouracil, Docetaxel - Breast Cancer, Pathological Complete Response | Phase 2 / Phase 3 | Unknown | Zhiyong Yu | 200 | 2017-11-27 | 2017-11-21 |
| DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer Fasting mimicking diet - Fasting Mimicking Diet, Breast Cancer | Phase 2 / Phase 3 | Completed | Leiden University Medical Center | 131 | 2014-02-01 | 2019-10-24 |
Breast Neoplasms (2)
Breast Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Cyclophosphamide (1) · Docetaxel (1) · Doxorubicin (1) · Epirubicin (1) · Fluorouracil (1)
Leiden University Medical Center (2) · Zhiyong Yu (1)
Netherlands (2)
Hanno Pijl, MD PhD (1) · Judith R Kroep, MD, PhD (1) · Judith R Kroep, PhD (1) · Xiaoshan Cao, MD (1) · Zhiyong Yu, PhD (1)